The Bone Density Solution Reviews: Publishes 2026 Consumer Education Update on Bone Density Testing and Osteoporosis Screening

Educational update explains DXA testing, T-scores, fracture-risk factors and questions adults can discuss with healthcare professionals without making clinical claims about the commercial program

BOISE, Idaho, September 17, 2026 — The Bone Density Solution, a digital educational guide by Shelly Manning, has issued a 2026 consumer education update explaining commonly used bone-density terminology, current U.S. osteoporosis screening recommendations and questions adults may consider discussing with qualified healthcare professionals.

The update focuses on dual-energy X-ray absorptiometry, commonly known as DXA or DEXA, bone mineral density measurements, T-scores, fracture history, medications, nutrition and physical activity.

It does not state that The Bone Density Solution increases bone mineral density, reverses osteoporosis, prevents fractures or produces a particular clinical outcome.

Instead, the educational material is intended to help readers distinguish general bone-health information from individualized diagnosis and treatment.

Current U.S. Preventive Services Task Force guidance recommends osteoporosis screening for women aged 65 years or older. The USPSTF also recommends screening postmenopausal women younger than 65 who are found to be at increased risk for an osteoporotic fracture following clinical risk assessment.

For men, the USPSTF currently concludes that available evidence is insufficient to determine the balance of benefits and harms of routine population screening.

“The purpose of this educational update is to help readers understand the terminology they may encounter when discussing bone health with a healthcare professional,” said Shelly Manning, author of The Bone Density Solution. “A T-score, fracture history, medication list and other risk factors need clinical context. Educational information should help people ask informed questions, not replace professional interpretation of their individual results.”

DXA Is Commonly Used to Measure Bone Mineral Density

The update begins with an explanation of DXA testing because bone-density reports can contain terminology that may be unfamiliar to patients.

A DXA scan uses low-dose X-rays to measure bone mineral density. Central DXA measurements commonly focus on areas including the hip and lumbar spine.

The test can provide information that healthcare professionals use when evaluating osteoporosis and fracture risk.

The Bone Density Solution does not recommend that every adult obtain a DXA scan.

Whether screening is appropriate depends on factors including age, gender, menopausal status, medical history, medication exposure and other clinical considerations.

The USPSTF’s current recommendation applies to adults aged 40 years or older without known osteoporosis or a history of fragility fracture and does not apply to certain people with secondary osteoporosis caused by an underlying medical condition or long-term use of medications associated with bone loss.

Consumers should therefore discuss the need for screening with an appropriate healthcare professional rather than relying on a general online recommendation.

Understanding What a T-Score Represents

The educational update also explains T-scores without encouraging readers to diagnose themselves.

A T-score compares a person’s bone mineral density with that of a healthy young-adult reference population. The National Institute of Arthritis and Musculoskeletal and Skin Diseases states that T-scores are commonly used when reporting bone-density results for postmenopausal women and men aged 50 years or older.

NIAMS describes a T-score of -1 or higher as being within the healthy range. A score between -1 and -2.5 indicates low bone mineral density, commonly called osteopenia.

A T-score of -2.5 or lower may indicate osteoporosis. Those categories should still be interpreted by a qualified healthcare professional. A T-score does not by itself describe every factor affecting an individual’s likelihood of sustaining a fracture, nor does a single number determine the appropriate treatment for every patient.

Fracture Risk Involves More Than Bone Density

The update emphasizes that bone mineral density represents one part of clinical assessment.

The USPSTF notes that many fragility fractures occur in people whose DXA T-scores are above -2.5. For that reason, healthcare professionals may consider bone-density measurements together with clinical risk factors.

Information that may be relevant includes age, prior fractures, family history, smoking, alcohol use, body weight, medications and medical conditions associated with increased fracture risk. Previous falls can also be relevant when discussing overall fracture prevention.

The educational update encourages readers to keep records of previous DXA scans and fracture history so that those details can be discussed with their healthcare professional. It does not provide its own fracture-risk calculation or assign readers to a treatment category.

Previous Fractures Are Important Clinical Information

A previous fracture can provide information that is not captured by a bone-density score alone. The update therefore suggests that adults preparing for a bone-health appointment note the date, location and circumstances of previous fractures. A fracture resulting from substantial trauma is different from a fracture occurring after relatively minor trauma, and the distinction may matter clinically.

Consumers should allow a healthcare professional to determine the significance of an individual fracture rather than categorizing it themselves based on an online guide. The Bone Density Solution does not claim that its educational content reduces fracture incidence.

Medication History Can Be Relevant to Bone Health

Another section of the update encourages consumers to maintain an accurate medication list. Some medications can affect bone health. For example, long-term glucocorticoid use is an established osteoporosis risk factor and is specifically identified in clinical guidance as an important consideration.

At the same time, medications are available for osteoporosis prevention or treatment in appropriately selected patients. The Bone Density Solution does not recommend discontinuing osteoporosis medication or replacing prescribed treatment with diet, exercise, supplements or other lifestyle measures.

Individuals taking prescription medicines should discuss any proposed medication change with the healthcare professional responsible for their treatment.

The educational update suggests questions such as:

• Could any of my current medications affect my bone health?

• Do I have risk factors that warrant bone-density testing?

• How should previous DXA results be interpreted?

• How will my bone health be monitored?

• Do my medications or medical conditions change which types of exercise are appropriate?

These questions are presented for discussion rather than as treatment recommendations.

Calcium and Vitamin D Have Established Roles in Bone Health

The update includes general information concerning calcium and vitamin D because both nutrients have established physiological roles relating to bone.

NIAMS explains that calcium is a major component of bone and that vitamin D helps the body absorb calcium. Recommended dietary intake differs according to age and gender.

However, the fact that calcium and vitamin D are important for normal bone health does not establish that taking additional supplements will increase bone density in every individual.

The Bone Density Solution does not claim that a particular calcium or vitamin D supplement can reverse osteoporosis.

Consumers should also not assume that more is necessarily better.

Someone considering a supplement may need to account for dietary intake, medical conditions, current medications and advice from a healthcare professional.

NIAMS advises people considering calcium supplementation to discuss it with a healthcare provider when appropriate.

Exercise Is Discussed as General Bone-Health Information

Physical activity is another subject covered in established bone-health guidance.

NIAMS identifies weight-bearing activity, resistance training and balance exercises among forms of physical activity relevant to maintaining bone and muscle health.

Exercise can also help improve strength, coordination and balance.

However, exercise recommendations should reflect the person’s health status.

Someone with established osteoporosis, previous fractures, balance problems or other physical limitations may require a modified exercise program.

NIAMS specifically advises people with low bone density, osteoporosis or physical limitations to speak with a healthcare professional before starting an exercise program.

The Bone Density Solution therefore does not claim that a particular exercise routine will produce a predetermined improvement in bone mineral density.

It also does not advise a person with osteoporosis to perform high-impact or potentially unsafe movements without appropriate professional guidance.

Educational Research Is Not Evidence for the Commercial Program

The 2026 update makes a specific distinction between general scientific research and evidence concerning The Bone Density Solution itself.

Studies examining exercise, calcium, vitamin D, dietary patterns or other bone-health subjects can help explain general scientific principles.

They do not demonstrate that a commercial educational program incorporating those topics produces the same outcome.

The existence of research supporting a particular activity or nutrient does not establish that following The Bone Density Solution will increase a user’s T-score, increase bone mineral density or prevent a future fracture.

No such product-specific clinical claim is made in this announcement.

Likewise, statements explaining that bone is living tissue and undergoes continuous remodeling should not be interpreted as evidence that a particular program can “rebuild” bones or reverse osteoporosis.

Those would be separate clinical claims requiring evidence appropriate to the specific program and outcome.

The Update Avoids Universal Osteoporosis Recommendations

Osteoporosis management is individualized. A person with mildly reduced bone mineral density and no previous fracture may have different clinical considerations from someone with established osteoporosis, previous vertebral fractures or a condition that contributes to secondary bone loss. Age, gender, medication use, medical history and fracture risk can all affect clinical decisions.

The Bone Density Solution’s educational update therefore does not provide one universal treatment protocol for everyone with low bone density. It also does not tell readers that conventional osteoporosis treatment is unnecessary. Medical treatment decisions should remain between patients and appropriately qualified healthcare professionals.

Questions Consumers Can Take to an Appointment

The education update suggests organizing several questions before a bone-health appointment.

Consumers may wish to ask:

Do my current risk factors indicate that DXA screening is appropriate?

Current recommendations differ according to age, gender, menopausal status and clinical risk.

What does my bone-density result mean for me personally?

T-scores provide useful information but should be interpreted with other clinical factors.

Do any of my medications or medical conditions affect my bone health?

Some medicines and health conditions can influence osteoporosis risk or management.

What nutrition and physical activity are appropriate for me?

General recommendations may need modification according to medical history, fracture history and physical ability.

Frequently Asked Questions

Does The Bone Density Solution claim to reverse osteoporosis?

No. This announcement does not claim that The Bone Density Solution reverses osteoporosis, restores lost bone, increases bone mineral density or produces a particular T-score. The program is educational and should not replace medical evaluation or osteoporosis treatment.

What does a T-score of -2.5 mean?

NIAMS states that a T-score of -2.5 or lower may indicate osteoporosis in populations for whom T-score interpretation is appropriate. A healthcare professional should interpret the result alongside medical history, fracture risk and other relevant information.

Does everyone need a DXA bone-density scan?

No. Current USPSTF recommendations support screening women aged 65 or older and postmenopausal women younger than 65 who are found to be at increased fracture risk after clinical assessment. Evidence is currently insufficient for the USPSTF to recommend for or against routine population screening in men. Individual screening decisions should be discussed with a healthcare professional.

Can diet, supplements or exercise replace osteoporosis medication?

This announcement does not make that recommendation. Nutrition and physical activity are relevant to general bone health, but people who have been prescribed osteoporosis medication should not discontinue or replace treatment on the basis of an educational program. Medication decisions should be made with the treating healthcare professional.

About The Bone Density Solution

The Bone Density Solution is a downloadable educational eBook by Shelly Manning and is listed by Blue Heron Health News among its digital health publications.

The material discusses bone-health topics including nutrition, physical activity and lifestyle considerations. The Bone Density Solution is educational content and is not a diagnostic service, medical treatment or substitute for care from qualified healthcare professionals. No statement in this announcement should be interpreted as a claim that the program itself has been clinically demonstrated to prevent fractures, reverse osteoporosis or increase bone mineral density.

Media Contact

Shelly Manning
The Bone Density Solution
Blue Heron Health News

1444 S. Entertainment Ave., Suite 410, Boise, ID 83709
Email: support@blueheronhealthnews.com
Phone: +1 (203) 872-9584

Research and Clinical Guidance Sources

U.S. Preventive Services Task Force — Osteoporosis to Prevent Fractures: Screening, Final Recommendation Statement, January 14, 2025.

National Institute of Arthritis and Musculoskeletal and Skin Diseases — Bone Mineral Density Tests: What the Numbers Mean.

National Institute of Arthritis and Musculoskeletal and Skin Diseases — Osteoporosis: Diagnosis, Treatment, and Steps to Take.

National Institute of Arthritis and Musculoskeletal and Skin Diseases — Calcium and Vitamin D: Important for Bone Health.

National Institute of Arthritis and Musculoskeletal and Skin Diseases — Exercise for Your Bone Health.

Medical Notice: This press release contains general educational information and does not provide medical advice, diagnosis or treatment. Individuals concerned about osteoporosis, fractures or low bone density should consult an appropriately qualified healthcare professional.